Company / Operating Cash Flow per Share
Oruka Therapeutics, Inc. Operating Cash Flow per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$3.44
FY2024
5-year range
-$3.44 / -$0.35
FY2020-FY2024
Trend
-890.0%
vs FY2023
Sector context
#176 of 212
Health Care
What the data says
Operating Cash Flow per Share changed -890% YoY in FY2024, a notable deviation from the 9-year average annual change of -147%.
Based on SEC 10-K filings.
-3.44 in FY2024.
Declined from $-1.30 to $-3.44 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 212This company -$3.44 Sector average $5.28
▼
-165.3% below sector average
Key checks
Key Insights
- In FY2024, operating cash flow per share decreased 890.0% year-over-year.
- Ranks #176 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2023.
- Lowest operating cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$3.44 | -890.0% |
| FY2023 | -$0.35 | +73.3% |
| FY2022 | -$1.30 | -60.9% |
| FY2021 | -$0.81 | +73.1% |
| FY2020 | -$3.01 | +71.7% |
| FY2019 | -$10.66 | -618.2% |
| FY2018 | -$1.48 | +10.1% |
| FY2017 | -$1.65 | -41.8% |
| FY2016 | -$1.16 | +62.6% |
| FY2015 | -$3.11 | -823.4% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026